Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

Clascoterone may be a promising treatment for hair loss.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Clascoterone safely promotes hair growth similar to minoxidil.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

Gene expression differences in PFS patients suggest a potential organic cause for symptoms.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.